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Primaryovarianﬁbrosarcomasareveryuncommonneoplasms.Sincethediagnosticcriteriawereestablishedin1981,lessthanone
hundred cases have been reported. This diagnosis can be diﬃcult to establish and other similar appearing mesenchymal processes
mustberuledout.Ineverycasethisdiagnosisisunderconsideration.Multiplesectionsofthespecimenandimmunohistochemical
stains will be necessary to support this diagnosis. The diﬃculty of recognition in frozen section in the majority of the situations
implies that the diagnosis should be deferred to the deﬁnitive study of the permanent sections with immunohistochemical studies.
There exists a histological resemblance between a primary ovarian ﬁbrosarcoma and actively mitotic ﬁbroma. In some cases, it
can be impossible to separate exactly these two entities. We report a well-diﬀerentiated ovarian ﬁbrosarcoma, with less than 1-2
mitosis ×10 HPF and low-grade cytological atypia, similar to active mitotic ﬁbromas, developing liver metastasis one year later.
Despite having distant metastasis, some cases with long survival rates have been reported in patients who received chemotherapy
after surgery; so that the adjuvant chemotherapy should be considered, especially in young females.
Copyright © 2009 Angel Garc´ ıa Jim´ enez et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
In Gynecology there is a wide spectrum of ovarian spindle
cell lesions developing from stromal ﬁbroblasts located at
the periphery of ovarian follicles. Amongst these lesions
there are ﬁbromas, thecomas, mitotically active ﬁbromas,
and ﬁbrosarcomas. The primary ovarian ﬁbrosarcomas
are extraordinarily rare neoplasm; the diagnostic criteria
include a mitotic index higher than 4 × 10HPF and
atypical cytology. Necrosis and haemorrhage are frequently
associated in these cases. Because they are uncommon
and can look like other malignant spindle cell pro-
cesses, the criteria of diﬀerentiation sometimes are not
clear, especially between mitotically active ﬁbromas and
ﬁbrosarcoma. Therefore these lesions may be prone for
misdiagnosis leading to in appropriate therapy especially
if intraoperative studies with frozen sections are used
primarily.
2.ClinicCase
A 55-year-old woman, without signiﬁcant pathologic
antecedents, had vaginal bleeding associated with notable
pelvic swelling. A giant heterogeneous ovarian mass of
23 × 15cm, without lymphadenopathy, was discovered by
ultrasound and CT scan image studies (Figure 1). The
patient underwent surgical excision of the mass. Ovarian
tumour removal was extremely diﬃcult due to the vast
adhesions to the anterior abdominal wall as consequence of
inﬁltrative margins. The uterine annexal tumour was sent
to the Department of Pathology with the aim to analyze
and rule out malignancy by means visual assessment of
frozen sections during intraoperative study. The lesion was
considered as a spindle cell tumour with no clear signs of
atypia, and with ﬁnal diagnoses deferred to histopatholog-
ical examination of the permanent sections. Because there
were grossly extensive necrotic areas, capsular disruption2 Case Reports in Medicine
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Figure 1: CT scanner image. Huge ovarian mass involving the
anterior abdominal wall can be appreciated.
Figure 2: Giant ovarian tumour with capsular disruption and
strong red surface colour due to haemorrhaging.
and many adhesions with other organs, excision using an
ovarian cancer protocol was performed. As a result, surgery
was completed with bilateral iliac and paraaortic lymph
node dissection, omentectomy, and cytological analysis of
peritoneal washings.
3.Pathologic Study
Grossly, the ovarian tumour measured 23 × 15cm, with
capsular disruption and a strong red external surface colour
(Figure 2). The cut surface of ovary showed multiple blood
ﬁlled cysts and solid but necrotic areas. Only 10%–20% of
the total of tumour consisted of viable tumour. The spec-
imen was sampled exhaustively. Microscopically, necrosis
and haemorrhage were reﬂected as major components. A
proliferation of spindle cells was found, frequently adopting
a storiform pattern. The cellular appearance consisted of
homogeneously appearing spindle-shaped cells and nuclei
with scant amounts of cytoplasm and ill-deﬁned margins
(Figure 3). Only a few of mitotic ﬁgures was found, with a
rate less than 1-2 × 10HPF. Even though the viable tumour
was mainly homogeneous with low number of mitotic
ﬁgures, the diagnosis of malignancy was rendered due to
other factors, such as necrosis, haemorrhage, ovarian cap-
sular disruption, and invasion of the neighbouring tissues.
Immunohistochemical stains only revealed a strong expres-
sion of vimentin. In order to rule out other mesenchymal
entities (GIST, leiomyosarcoma, dendritic cell proliferations,
and sarcomatoid carcinomas) other immunostains were
performed, such as cocktails of cytokeratins, CD117 (c-
kit), smooth muscle actin, H-caldesmon, neuron speciﬁc
enolase, CD21, CD22, and CN4A. All of these antiboﬁes
stained negative in the tumour cells. On the other hand,
a nuclear expression for Ki 67 (MIB-1) was seen in more
than 60% of total cells, despite the infrequent number of
mitotic ﬁgures. In the complementary specimens (uterus,
lymphnodes,omentum,peritoneum)therewasnodeﬁnitive
evidence of malignancy. The case was diagnosed as ovarian
ﬁbrosarcoma, stage pT1c No Mo/I C (FIGO).
After the diagnosis, the patient underwent adju-
vant chemotherapy. A combination of 4 -epidoxorubicin
60mg/m2 on days 1 and 2 and ifosfamide 1.8g/m2 on
days 1 through 5, with hydration, mesna, and granulocyte
colony-stimulating factor were administrated, according to
the Italian co-operative study with adjuvant chemotherapy
for soft tissue sarcoma [1]. After a disease free interval of
14 months, one metastatic liver nodule was detected. The
hepatic lesion was removed and the histology was identical
to the primary ovarian tumour.
4. Discussion
Primary ovarian ﬁbrosarcoma is an extremely rare entity
[2, 3]. They are considered to have originated directly
from stromal cells around the sex cord of ovarian follicles.
Alternatively, a malignant transformation of a previous
ﬁbroma is also believed to be a potential origin as well. These
tumours occur at any age although most of them appear
in menopausal and postmenopausal women. Clinically, the
patients note abdominal swelling as a result of large pelvic
masswithacceleratedgrowth.Themajorityoftumoursshow
areas of necrosis and haemorrhage, capsular disruption as
well as inﬁltrative margins that make adhesions with other
pelvic organs. Microscopically, similar to ﬁbrosarcomas in
other locations, there is a high cellularity often there is a
moderate cellular pleomorphism and an average of 4 or
more mitotic ﬁgures × 10HPF [3]. In some cases, trisomy
12 or 18 has been reported in these neoplasms [4]. Usually,
the prognosis is poor, with early distant metastases, show-
ing resistance to some adjuvant chemotherapy regiments,
although recently several cases have been reported with long
posttreatment survival rates [5].
Diagnosis is diﬃcult because there are not speciﬁc
patterns of immunohistochemical staining or molecular
studies for this sort of neoplasm. Before making a diagnosis
of primary ovarian ﬁbrosarcoma, other spindle cell lesions
should be ruled out. In this sense, some Krukenberg’s
tumours have a large component of spindle cells, and
in some cases the epithelial cells can be identiﬁed only
after an extensive sampling [6, 7]. Similarity, sarcomatoid
carcinomas might have similar histology as ﬁbrosarcomaCase Reports in Medicine 3
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Figure 3: (a) Spindle cells appear with relatively homogeneous nuclei and scant cytoplasm. Low-grade atypia and few number of mitosis
can be observed. H/E 400X. (b) the ki-67 immunostain shows a 60% nuclear expression of all spindle cells among the interstitial collagen.
[6] and require immunohistochemical stains or ultrastruc-
tural study to demonstrate their epithelial nature. Primary
ovarian leiomyosarcomas and ovarian invasion from uterine
origin might be mistaken as ﬁbrous neoplasms. However,
leiomyosarcomas tend to show a higher grade of cellular
pleomorphism and immunostains with speciﬁc markers
for smooth muscle. Sometimes, ovarian sex cord tumours
are also associated with a vast spindle cell component,
mimicking sarcomatoid lesions. In these cases it is necessary
to make an exhaustive sampling to minimize misdiagnosis,
and in some cases stain for inhibin, although some stromal
cells can be positive as well [8].
In the diﬀerential diagnosis of these spindle-shaped
lesions, we should also consider the possibility of gastroin-
testinal stromal tumours involving the ovary; in these cases,
immunostain for CD117 or molecular studies, evaluating c-
kit mutations, would be essential [9, 10]. Other processes
that eventually aﬀect the ovary are endometrial stromal
sarcomas which must be taken into account, especially
those with a spindle shaped cell pattern. These cases will
need immunohistochemistry with CD10 to demonstrate
their stromal nature [11]. More rarely, some tumours with
occasional spindle cell or sarcomatoid pattern can involve
the ovary such as dendritic cell neoplasms and melanomas,
where immunohistochemical stains will be also necessary
[12, 13]. Finally, ovarian metastases of sarcomas originating
in other locations should also be ruled out.
Generally, the spectrum of ovarian ﬁbrous tumours is
wide and the diagnostic criteria are not always clear and
therefore the management of these patients may not be
appropriate. There are no problems distinguishing a ﬁbroma
from ﬁbrosarcoma; however, the recognition of a mitotically
active ﬁbroma is not clear. Mitotically active ﬁbromas have
been deﬁned as spindle cell tumours with low mitotic rate
(lessthan4×10HPF),withoutatypicalcytology,necrosis,or
inﬁltrative margins. On the contrast, ovarian ﬁbrosarcomas
usually have higher mitotic rate and have atypical cytology
[3]. Usually, these criteria should not give rise to any
problems, but Irving et al. recently reported that the mitotic
activity was not the unique criteria of malignancy [9].
These authors studied 75 ovarian ﬁbrosarcomas, including
45 mitotically active ﬁbromas. Ovarian ﬁbrosarcomas fre-
quently show cellular atypia or pleomorphism besides a high
mitotic activity. In addition, they considered that ﬁbrosar-
comas usually had a short history of accelerated growth and
weretumourswithadhesions,necrosis,andhaemorrhage.In
contrast, mitotically active ﬁbromas had no cellular atypia,
their gross sizes were smaller and adhesions, necrosis or
haemorrhage were absent in their series. However, not all of
these histological diﬀerences can be discriminatory between
a ﬁbrosarcoma and mitotically active ﬁbromas. In our case,
despite having low degree of atypical cytology and few
numbers of mitotic ﬁgures, this tumour metastasized to the
liver one year later. A discrepant clue in our case leading
to our diagnosis of malignancy was the discrepant Ki-67
stainingcomparedtothevisualassessmentofmitoticﬁgures.
Several diﬀerent series with several tumours with criteria
of ﬁbrosarcomas had a good survival outcome and long
unexpected survivals after adjuvant chemotherapy have been
reported [5]. These experiences bring us the hypothetical
idea that mitotically active ﬁbroma and ﬁbrosarcoma could
be the same neoplasm with diﬀerent degree of evolution. In
other words, there still exists an overlapping between several
ovarianspindlecelltumoursthatmaycomplicatethesuitable
management of these patients.
In conclusion, these ﬁndings imply that we still have
no clearly deﬁned morphologic criteria to diﬀerentiate these
proliferative spindle shaped cell processes. The histology
is diﬃcult, and there are no speciﬁc immunostains or
molecularfactorscapableofidentifyingthebiologicalbehav-
ior. More studies will be necessary to identify predictive
factorsofbehavior.Moreover,theintraoperativestudieswith
frozen sections, that are useful in epithelial tumours, can be
extraordinarily diﬃcult to read, and in this sense, no cases4 Case Reports in Medicine
of ovarian ﬁbrosarcoma have been reported yet. We recom-
mend caution in the diagnosis by frozen sections. In these
situations, we prefer make the diagnosis only as proliferative
spindle cell tumour, without excluding a malignant nature
and wait to deﬁnitive study of permanent sections from
extensive sampling. Under these circumstances, gynecolog-
ical surgeons need to evaluate other additional parameters
intraoperatively, such as the existence of capsular disruption,
necrosis, or haemorrhage that allows a greater suspicion
of malignancy. In these tumours, not only the histological
appearance should prevail but the clinical signs (accelerated
growth, adhesions) and direct exam of surgical specimen
(necrosis, haemorrhage) have to be evaluated as well. In
addition, high rates for antigen of proliferation Ki67 (MIB-
1), as in our case (above 60%), could contribute to the
diagnosis of malignancy, despite having a low visual mitotic
rate.
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